Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05638698
Title Tg01 Vaccine / Qs-21 Stimulon™ With Or Without Balstilimab As Maintenance Therapy Following Adjuvant Chemotherapy In Patients With Resected Pancreatic Cancer (TESLA)
Acronym TESLA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Kansas Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Kansas Cancer Center - Clinical Research Center RECRUITING Fairway Kansas 66208 United States Details
University of Kansas Cancer Center - Overland Park RECRUITING Overland Park Kansas 66210 United States Details
University of Kansas Cancer Center - Westwood RECRUITING Westwood Kansas 66205 United States Details
University of Kansas Cancer Center - North RECRUITING Kansas City Missouri 64154 United States Details
University of Kansas Cancer Center - Lee's Summit RECRUITING Lee's Summit Missouri 64064 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field